Comparison
Company
Score
Quality
Valuation
Financial
Technical
Why is Shandong Xinhua Pharmaceutical Co., Ltd. ?
1
Poor long term growth as Operating profit has grown by an annual rate -1.75% of over the last 5 years
2
With ROE of 8.55%, it has a Very Expensive valuation with a 0.27 Price to Book Value
- The stock is trading at a fair value compared to its peers' average historical valuations
- Over the past year, while the stock has generated a return of 14.96%, its profits have fallen by -11.8%
3
Underperformed the market in the last 1 year
- The stock has generated a return of 14.96% in the last 1 year, much lower than market (Hang Seng Hong Kong) returns of 27.36%
How much should you sell?
- All quantity irrespective of whether you are making profits or losses
(If sector exposure > 30%, please use optimiser tool to see which are the best stocks to hold in Pharmaceuticals & Biotechnology)
When to re-enter? - We will constantly monitor the company and review our call based on new data
Is Shandong Xinhua Pharmaceutical Co., Ltd. for you?
Low Risk, Medium Return
Absolute
Risk Adjusted
Volatility
Shandong Xinhua Pharmaceutical Co., Ltd.
14.96%
0.66
35.15%
Hang Seng Hong Kong
27.36%
1.06
25.88%
Quality key factors
Factor
Value
Sales Growth (5y)
7.30%
EBIT Growth (5y)
-1.75%
EBIT to Interest (avg)
9.96
Debt to EBITDA (avg)
1.10
Net Debt to Equity (avg)
0.18
Sales to Capital Employed (avg)
1.22
Tax Ratio
9.88%
Dividend Payout Ratio
40.16%
Pledged Shares
0
Institutional Holding
0
ROCE (avg)
9.18%
ROE (avg)
10.46%
Valuation Key Factors 
Factor
Value
P/E Ratio
3
Industry P/E
Price to Book Value
0.27
EV to EBIT
4.63
EV to EBITDA
2.09
EV to Capital Employed
0.36
EV to Sales
0.26
PEG Ratio
NA
Dividend Yield
3.57%
ROCE (Latest)
7.72%
ROE (Latest)
8.55%
Technical key factors
Indicator
Weekly
Monthly
MACD
Mildly Bearish
Bullish
RSI
No Signal
No Signal
Bollinger Bands
Bearish
Mildly Bullish
Moving Averages
Mildly Bullish (Daily)
KST
Bearish
Bullish
Dow Theory
Mildly Bullish
No Trend
OBV
Mildly Bullish
No Trend
Technical Movement
Not enough Data to analyse Financial Trend
Not enough Data to analyse Financial Trend
Here's what is working for Shandong Xinhua Pharmaceutical Co., Ltd.
Operating Profit
Highest at HKD 264.54 MM
in the last five periodsMOJO Watch
Near term Operating Profit trend is positive
Operating Profit (HKD MM)
Operating Profit Margin
Highest at 11.61 %
in the last five periodsMOJO Watch
Company's profit margin has improved
Operating Profit to Sales
Pre-Tax Profit
Highest at HKD 107.51 MM
in the last five periodsMOJO Watch
Near term Pre-Tax Profit trend is positive
Pre-Tax Profit (HKD MM)
Net Profit
Highest at HKD 89.28 MM
in the last five periodsMOJO Watch
Near term Net Profit trend is positive
Net Profit (HKD MM)
EPS
Highest at HKD 0.15
in the last five periodsMOJO Watch
Increasing profitability; company has created higher earnings for shareholders
EPS (HKD)
Inventory Turnover Ratio
Highest at 5.57%
in the last five Semi-Annual periodsMOJO Watch
Company has been able to sell its inventory faster
Inventory Turnover Ratio
Raw Material Cost
Fallen by -12.99% (YoY)
MOJO Watch
The company's ability to pass on the cost of raw materials to customers has improved; this may lead to a rise in profit margin
Raw Material Cost as a percentage of Sales
Here's what is not working for Shandong Xinhua Pharmaceutical Co., Ltd.
Dividend per share
Lowest at HKD 7.29
in the last five yearsMOJO Watch
Company is distributing lower dividend than previous years
DPS (HKD)






